Постковидный синдром – что мы знаем о нем?

Анастасия Алексеевна Бакина; Валентина Ивановна Павленко; Юлия Юрьевна Щегорцова

��

LITERATURE REVIEW

��

�� 578.834.1: 616.98: 616.24-002.153

https://doi.org/10.24412/2311-5068-2023-11-1-5

�� ?

�� , �� ,

��

�� , ��, ��,

anastasia_darchi@mail.ru, agmapedfac@mail.ru, shchegortsova92@mail.ru

��. ��

�� (��). ��

��: ��

��, �� 3 ��. ��

�� , �� . �� ,

��, �� , �� , �� ,

�� , ��

��. �� ,

�� , ��, ��- �� . ��

�� , �� -��, �� .

�� , ��,

�� , �� ,

�� . �� . � ��

�� , � ��

�� . �� 8 ��

�� COVID-19, � �� , ��

�� 1 �� . ��, ��

��

COVID-19. �� , � �� , �� ,

�� . ��

�� COVID-19 �� , ��

��, �� .

�� : �� , COVID-19, �� , ��,

��.

�� : �� .�., �� .�., �� .�. ��

� �� ? // �� . 2023. �� 11. � 1(34). �. 5-15.

https://doi.org/10.24412/2311-5068-2023-11-1-5

Review article

WHAT DO WE KNOW ABOUT POST-COVID SYNDROME?

Anastasiya A. Bakina, Valentina I. Pavlenko, Yuliya Yu. Shchegortsova

Amur State Medical Academy of the Ministry of Health of the Russian Federation,

Blagoveshchensk, Russia,

anastasia_darchi@mail.ru, agmapedfac@mail.ru, shchegortsova92@mail.ru

Abstract. The study of post-COVID syndrome (PCS) is relevant. The aim of the review is to study and

summarize data on the features of PCS from the literature over the past 3 years. Manifestations of PCS

� �� .�., �� .�., �� .�., 2023

have many variants, different duration and severity. Patients with PCS suffer from fatigue, mood swings and

persistent respiratory symptoms, cognitive and psycho-emotional disturbances. Frequent neuropsychiatric

manifestations of PCS are speech disorders, headache, dysgeusia, hypo- or anosmia. Severe PCS can

provoke the development of acute cerebrovascular accident, Guillain-Barre syndrome, encephalitis or

encephalopathy. The researchers found that the symptoms of PCS can range from persistent cough, dyspnea

and postural orthostatic tachycardia to renal failure, myocarditis, and pulmonary fibrosis. The persistence

of manifestations of PCS can be different. Often, PCS is completely stopped, but in some patients it has

persistent manifestations. The researchers found that tachycardia and cardialgia disappeared in 8 months

after suffering COVID-19. Fatigue and dyspnea persisted up to 1 year after experiencing COVID-19. The

number of chronic somatic pathologies is associated with the incidence of increased fatigue and dyspnea

after suffering from COVID-19. Thus, it was found that the manifestations of PCS have a multisystem

character and long-term persistence. Most often there are feelings of fatigue, a decrease in tolerance to

physical activity, cognitive and psycho-emotional disorders after suffering from COVID-19.

Keywords: coronavirus infection, COVID-19, post-COVID syndrome, tiredness, dyspnea.

For citation: Bakina AA, Pavlenko VI., Shchegortsova Yu.Yu. Postkovidnyi sindrom � chto my znaem

o nem? [What do we know about post-COVID syndrome?]. Amurskii meditsinskii zhurnal. � Amur Medical

Journal, 2023;11;1(34):5�15. (In Russ.). https://doi.org/10.24412/2311-5068-2023-11-1-5

�� 2019 ��

��

(��) [21]. �� , ��

�� -��

.-��, ��

��

�� 2 (SARS-CoV-2), � ��

��

(COVID-19) [7, 31].

��

COVID-19 ��

��, ��

��

[40]. COVID-19 ��

��

�� . ��, �

�� 2020 �. ��

�� 80 ��

�� [20,

31, 32], � � �� 2021 �. ��

COVID-19 � �� 275 ��

[11]. ��

�� , ��

�� , �� ,

�� ,

�� , ��

�� -��,

��, ��, ��

[2, 3, 21, 39].

��

��, �� COVID-19

� ��

��

� ��

��, ��

� �� COVID-19 [13, 38].

��, ��

iНе можете найти то, что вам нужно? Попробуйте сервис подбора литературы.

�� , ��

�� COVID-19 � ��

�� ,

��

��, ��

�� .

��

�� (��) [33, 35].

��

��, ��

COVID-19, ��

��, �� 3 ��

COVID-19, � ��, ��

�� 2 ��

�� [40]. ��

�� 10,8 % �� ,

�� COVID-19, ��

�� , �

��

�� [22].

� ��

��

�� , ��

� �� , ��

�� , ��

��

�� .

�� : ��

��

� ��

��, ��

�� 3 ��.

�� ,

�� .

�� , ��

��

�� . ��, �� ,

�� C�VID-19, ��

�� ,

�� , ��

��

�� [16, 19, 41].

��

COVID-19 ��

�� , ��

�� [18, 22].

��, ��-�� Ceban F. � ��. (2022), ��,

�� 32 % ��, �� COVID-19,

��

� ��

�� (�� 12

� �� ), � ��

�� 22 % ��. ��

�� , ��

�� 1,5 �� , ��

�� [6]. � �� Davis H.E. � ��.

(2021), �� 3762 ��, ��

COVID-19, �� , ��

��

�� 6 ��

�� .

�� , ��

��

��, ��

�� , �� ,

� ��

�� [12].

� ��

��

�� (49 %), �� (77 %), ��

�� (88 %),

�� , ��- ��

�� (58 %) [12]. �� ,

�� (��

�� ) ��

��

COVID-19. �� , ��

��

��, � � ��

��

�� [14]. Kamal �. � ��. (2021),

�� , �� 287 ��,

� �� ,

��, �� , ��

��

(28,6 %) � �� (28,6 %) [22].

��

�� , ��

�� ,

��

�� , ��

� �� , �� -

��, ��

iНе можете найти то, что вам нужно? Попробуйте сервис подбора литературы.

[42].

� �� ,

��

�� COVID-19 ��

��

�� , ��, �� ,

�� , ��

�� [42].

� ��

�� , ��

�� SARS-CoV-2 ��

��

��. ��, ��

��

��, �� , ��

��

[27]. ��

�� , ��

�� SARS-CoV-2

��

AChR. �� , �� ,

��

� AChR, ��

��, ��

[8].

��

(28,2 %) � �� (23,0 %) [9, 18, 22]. ��

��

�� , ��

��

�� (��) [19]. ��, ��

��, ��

��, �� COVID-19, ��

�� 30 % [12]. Chung T.H. �

Azar A. (2022), ��

��, �� (��

COVID-19), ��, ��

��

��, � ��

��, �� , �� .

��

(��-��, ��

�� , ��

��) �� . ��,

��, ��

�� , �

��

�� . � ��

��

��. � ��

��, ��

��

� �� , �� (��

�� COVID-19) [10].

� �� ,

�� COVID-19 ��

�� , ��

��, ��

[1, 22]. �� , � 12 %

��, �� COVID-19, �� 3

��

�� , � 8,4 %

� �� [28]. ��

��-�� 30 ��

��

�� , ��

�� COVID-19 (�� 36 % ��

6 �� 18 % � ��

12 ��). �� , ��

��

�� [23]. Lee J.H.

� ��. (2022), �� -��

��, ��, ��

��

� ��

�� (�� 35 %

�� COVID-19). � ��

� 12-��

��

�� , �� 6-�� ,

��

�� [23].

�� , ��

��

��. ��, ��, ��

��

�� ,

�� , ��

[12].

��

��. � 67,6 % ��

��, � �� 32,4 %

iНе можете найти то, что вам нужно? Попробуйте сервис подбора литературы.

��

[22]. �� , ��

�� 3 ��

COVID-19 �� , ��

�� [18]. Nateghi S.

� ��. (2022) ��, �� 3 ��

�� COVID-19 ��

�� ,

�� [28]. � ��

�� Mizrahi B.

� ��. (2023) �� , ��

�� COVID-19

�� ,

� �� , ��

��

1 �� .

��

� �� 8 ��

�� COVID-19, � ��

��

4 ��

�� 12 ��. ��

�� :

�� , ��

�� ,

� ��

7 �� . [26]. ��-��,

�� Yang T. � ��. (2022), ��,

��

�� , ��

��, �� 26,2 % � 15,1 %

��, �� COVID-19, � ��

�� 12 �� [43].

��

�� , ��

�� , � �

��

��-�� . ��

�� ,

�� , � ��

�� 47780 ��, ��

COVID-19. � �� , ��

140 �� ,

��

COVID-19, ��

�� , �

��

�� 12 %,

�� , ��

� 4 � 8 �� [5].

��

� ��, ��

��

��, ��

�� SARS-CoV-2, ��

��

COVID-19 [4, 24, 29, 36, 37]. ��

��, ��

�� COVID-19 � ��

��, ��, ��

�� 20 ��, ��

��

� 2 �� , �� [41]. ��

��-�� , ��

��

� �� , �� .

��, �� , ��

�� 50 % ��, ��

�� [29]. ��

��

��, �� . � ��

�� , ��

��

�� [29], ��

��

�� [30], � Subramanian A. �

��. (2022) ��, ��

70 �� , ��

30�39 �� [37]. �� Wulf Hanson

S. � ��. (2022), ��

�� 9 �� ,

�� COVID-19 ��

��, � �� 4 ��

�� [41]. ��

��

� ��

�� COVID-19 �

��

[16]. ��

��

� ��

��

COVID-19 [25, 29]. ��

��, �� ,

��, ��

�� (�� 6

iНе можете найти то, что вам нужно? Попробуйте сервис подбора литературы.

��) ��: ��

� �� ,

��

�� D-��

[44]. � �� Fernandez-de-Las-Penas C.

� ��. (2021), �� 289 ��,

�� 7 ��

�� , �� , ��

��

��, ��

��

� � �� [15]. ��, ��

�� (��

��, ��, ��,

��, ��,

��, ��

��) ��

�� , ��

COVID-19 � ��

��, � ��

COVID-19 [17, 19]. �� , ��

� �� ,

��

�� , ��

��

�� [9, 25, 34].

��

�� COVID-19 � ��

��, ��

�� .

��

COVID-19 �� ,

�� ,

��

��. ��

��

��, �� , �� .

��

�� , ��

�� ,

��, �� ,

�� .

�� , ��

��

�� , ��, ��, �

��

�� .

��

1. �� . �., �� . �., �� . �. ��

COVID-19 � �� // XXXII �� : �� ;

�� . �.�. ��. �� : ��, 2022. �. 77.

2. �� . �., �� . �., �� . �. �� , ��

�� // XXXII ��

�� : �� ; �� . �.�. ��. �� : ��, 2022. �. 130.

3. �� . �., �� . �., �� . �. �� -��

� ��

// �� . 2022. � 85. �.26-31. https://doi.org/10.36604/19985029-

2022-85-26-31.

4. �� .�., �� .�., �� .�. ��

�� COVID-19 // �� . 2021. � 1(31). �.11-17.

https://doi.org/10.24412/2311-5068-2021-1-11-17. EDN: NHRQCQ.

5. Ayoubkhani D., Khunti K., Nafilyan V., Maddox T., Humberstone B., Diamond I., Banerjee A. Post-

COVID syndrome in individuals admitted to hospital with covid-19: retrospective cohort study // BMJ. 2021.

� 372. �. n693. https://doi.org/10.1136/bmj.n693.

6. Ceban F., Ling S., Lui L.M.W., Lee Y., Gill H., Teopiz K.M., Rodrigues N.B., Subramaniapillai M., Di

Vincenzo J.D., Cao B., Lin K., Mansur R.B., Ho R.C., Rosenblat J.D., Miskowiak K.W., Vinberg M., Maletic V.,

McIntyre R.S. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and metaanalysis

/ // Brain Behav Immun. 2022. � 101. P. 93-135. https://doi.org/10.1016/j.bbi.2021.12.020.

7. Chan J.F., Yuan S., Kok K.H., To K.K., Chu H., Yang J., � ��. A familial cluster of pneumonia associated

with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster //

Lancet. 2020. Vol. 395. P. 514-523. https://doi.org/10.1016/S0140-6736(20)30154-9.

8. Changeux J.P., Amoura Z., Rey F.A., Miyara M. A nicotinic hypothesis for COVID-19 with preventive

and therapeutic implications // C R Biol. 2020. � 343(1). �.1�7. https://doi.org/10.5802/crbiol.8. PMID:

32720486.

9. Chudzik M., Babicki M., Kapusta J., Kaluzinska-Kolat Z., Kolat D., Jankowski P., Mastalerz-Migas A.

Long-COVID clinical features and risk factors: a retrospective analysis of patients from the STOP-COVID

registry of the PoLoCOV study // Viruses. 2022. � 14(8). �.1755. https://doi.org/10.3390/v14081755.

10.Chung T.H., Azar A. Autonomic nerve involvement in post-acute sequelae of SARS-CoV-2 syndrome

(PASC) // J Clin Med. 2022. � 12(1). �. 73. https://doi.org/10.3390/jcm12010073.

11. Coronavirus disease (COVID-19) � World Health Organization. Accessed June 27, 2021. https://

www.who.int/emergencies/diseases/novel-coronavirus-2019.

12. Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re�em Y., � ��. Characterizing long COVID in an

international cohort: 7 months of symptoms and their impact // E Clinical Medicine. 2021. � 38. P. 101019.

https://doi.org/10.1016/j.eclinm.2021.101019.

13.Feikin D.R., Higdon M.M., Abu-Raddad L.J., Andrews N., Araos R., Goldberg Y., Groome M.J., Huppert

A., O�Brien K.L., Smith P.G., Wilder-Smith A., Zeger S., Deloria Knoll M., Patel M.K. Duration of effectiveness

of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and metaregression

// Lancet. 2022. Vol. 399. P. 924-944. https://doi.org/10.1016/S0140-6736(22)00152-0.

14.Fernandez-de-Las-Penas C., Gomez-Mayordomo V., Cuadrado M.L., Palacios-Cena D., Florencio L.L.,

Guerrero A.L., Garcia-Azorin D., Hernandez-Barrera V., Arendt-Nielsen L. The presence of headache at onset

in SARS-CoV-2 infection is associated with long-term post-COVID headache and fatigue: A case-control

study // Cephalalgia. 2021. � 41(13). �.1332-1341. https://doi.org/10.1177/03331024211020404.

15.Fernandez-de-Las-Penas C., Guijarro C., Torres-Macho J., Velasco-Arribas M., Plaza-Canteli S.,

iНе можете найти то, что вам нужно? Попробуйте сервис подбора литературы.

Hernandez-Barrera V., Arias-Navalon J.A. Diabetes and the risk of long-term post-COVID symptoms //

Diabetes. 2021. � 70(12). �.2917-2921. https://doi.org/10.2337/db21-0329.

16.Fernandez-de-Las-Penas C., Rodriguez-Jimenez J., Cancela-Cilleruelo I., Guerrero-Peral A., Martin-

Guerrero J.D., Garcia-Azorin D., Cornejo-Mazzuchelli A., Hernandez-Barrera V., Pellicer-Valero O.J. Post-

COVID-19 symptoms 2 years after SARS-CoV-2 infection among hospitalized vs nonhospitalized patients //

JAMA Netw Open. 2022. � 5(11). �.e2242106. https://doi.org/10.1001/jamanetworkopen.2022.42106.

17.Fernandez-de-Las-Penas C., Ryan-Murua P., Rodriguez-Jimenez J., Palacios-Cena M., Arendt-

Nielsen L., Torres-Macho J. Serological biomarkers at hospital admission are not related to long-term post-

COVID fatigue and dyspnea in COVID-19 survivors // Respiration. 2022. � 101(7). �. 658�665. https://doi.

org/10.1159/000524042.

18.Goertz YMJ, Van Herck M, Delbressine JM, Vaes AW, Meys R, Machado FVC, Houben-Wilke S, Burtin

C, Posthuma R, Franssen FME, van Loon N, Hajian B, Spies Y, Vijlbrief H, van �t Hul AJ, Janssen DJA, Spruit

MA. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open

Res. 2020 Oct 26;6(4):00542-2020. https://doi.org/10.1183/23120541.00542-2020. PMID: 33257910; PMCID:

PMC7491255.

19.Guntur V.P., Nemkov T., de Boer E., Mohning M.P., Baraghoshi D., Cendali F.I., San-Millan I., Petrache

I., D�Alessandro A. Signatures of mitochondrial dysfunction and impaired fatty acid metabolism in plasma of

patients with post-acute sequelae of COVID-19 (PASC) // Metabolites. 2022. � 12(11). �.1026. https://doi.

org/10.3390/metabo12111026.

20.Holshue M.L., DeBolt C., Lindquist S., Lofy K.H., Wiesman J., Bruce H., Spitters C., Ericson K., Wilkerson

S., Tural A., Diaz G., Cohn A., Fox L., Patel A., Gerber S.I., Kim L., Tong S., Lu X., Lindstrom S., Pallansch M.A.,

Weldon W.C., Biggs H.M., Uyeki T.M., Pillai S.K. Washington State 2019-nCoV Case Investigation Team. First

Case of 2019 Novel Coronavirus in the United States // N Engl J Med. 2020. Vol. 382. � 10. �. 929-936.

https://doi.org/10.1056/NEJMoa2001191.

21.Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., Cheng Z., Yu T., Xia J., Wei

Y., Wu W., Xie X., Yin W., Li H., Liu M., Xiao Y., Gao H., Guo L., Xie J., Wang G., Jiang R., Gao Z., Jin Q., Wang J.,

Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China // Lancet. 2020.

Vol. 395. P. 497�506. https://doi.org/10.1016/S0140-6736(20)30183-5.

22.Kamal M., Abo Omirah M., Hussein A., Saeed H. Assessment and characterisation of post-COVID-19

manifestations // Int J Clin Pract. 2021. � 75. �. e13746. https://doi.org/10.1111/ijcp.13746.

23.Lee J.H., Yim J.J., Park J. Pulmonary function and chest computed tomography abnormalities 6-12

months after recovery from COVID-19: a systematic review and meta-analysis // Respir Res. 2022. � 23(1).

�. 233. https://doi.org/10.1186/s12931-022-02163-x.

24.Liang L., Yang B., Jiang N., Fu W., He X., Zhou Y., Ma W.L., Wang X. Three-month Follow-up Study of

Survivors of Coronavirus Disease 2019 after Discharge // J Korean Med Sci. 2020. � 35(47). �. e418. https://

doi.org/10.3346/jkms.2020.35.e418.

25.Loosen S.H., Jensen B.O., Tanislav C., Luedde T., Roderburg C., Kostev K. Obesity and lipid metabolism

disorders determine the risk for development of long COVID syndrome: a cross-sectional study from 50,402

COVID-19 patients // Infection. 2022. � 50(5). �.1165-70. https://doi.org/10.1007/s15010-022-01784-0.

26.Mizrahi B., Sudry T., Flaks-Manov N., Yehezkelli Y., Kalkstein N., Akiva P., Ekka-Zohar A., Ben David

S.S., Lerner U., Bivas-Benita M., Greenfeld S. Long COVID outcomes at one year after mild SARS-CoV-2

infection: nationwide cohort study // BMJ. 2023. � 380. �.e072529. https://doi.org/10.1136/bmj-2022072529.

27.Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S.,

Shalev D., Sehrawat T.S., Ahluwalia N., Bikdeli B., Dietz D., Der-Nigoghossian C., Liyanage-Don N., Rosner G.F.,

Bernstein E.J., Mohan S., Beckley A.A., Seres D.S., Choueiri T.K., Uriel N., Ausiello J.C., Accili D., Freedberg D.E.,

Baldwin M., Schwartz A., Brodie D., Garcia C.K., Elkind M.S.V., Connors J.M., Bilezikian J.P., Landry D.W., Wan

E.Y. Post-acute COVID-19 syndrome // Nat Med. 2021. Vol. 27. � 4. P. 601-615. https://doi.org/10.1038/

s41591-021-01283-z.

28.Nateghi S., Hesari E., Mansouri F., Akrami M., Pourian M., Khosravani A., Taghizadeh F., Akbarpour S.,

Faraji N. Evaluation of blood biochemistry and cardiopulmonary status of hospitalized COVID-19 patients

in 3 months post discharged follow up survey // Clin Med Insights Circ Respir Pulm Med. 2022. � 16.

�.11795484221119332. https://doi.org/10.1177/11795484221119332.

29.Notarte K.I., de Oliveira M.H.S., Peligro P.J., Velasco J.V., Macaranas I., Ver A.T., Pangilinan F.C., Pastrana

A., Goldrich N., Kavteladze D., Gellaco M.M.L., Liu J., Lippi G., Henry B.M., Fernandez-de-Las-Penas C. Age,

sex and previous comorbidities as risk factors not associated with SARS-CoV-2 infection for long COVID-19:

A Systematic Review and Meta-Analysis // J Clin Med. 2022. � 11(24). �.7314. https://doi.org/10.3390/

jcm11247314.

30.Peghin M., Palese A., Venturini M., De Martino M., Gerussi V., Graziano E., Bontempo G., Marrella

F., Tommasini A., Fabris M., Curcio F., Isola M., Tascini C. Post-COVID-19 symptoms 6 months after acute

infection among hospitalized and non-hospitalized patients // Clin Microbiol Infect. 2021. � 27(10).

�.1507�1513. https://doi.org/10.1016/j.cmi.2021.05.033.

31.Phan L.T., Nguyen T.V., Luong Q.C., Nguyen T.V., Nguyen H.T., Le H.Q., Nguyen T.T., Cao T.M., Pham

Q.D. Importation and Human-to-Human Transmission of a Novel Coronavirus in Vietnam // N Engl J Med.

2020. Vol. 382. � 9. P. 872-874. https://doi.org/10.1056/NEJMc2001272.

32.Rothe C., Schunk M., Sothmann P., Bretzel G., Froeschl G., Wallrauch C., Zimmer T., Thiel V., Janke

C., Guggemos W., Seilmaier M., Drosten C., Vollmar P., Zwirglmaier K., Zange S., Wolfel R., Hoelscher M.

Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany // N Engl J Med. 2020. Vol.

382. � 10. P. 970-971. https://doi.org/10.1056/NEJMc2001468.

33. Rubin R. As their numbers grow, COVID-19 �Long haulers� stump experts // JAMA. 2020. Vol. 324.

� 14. P.1381�1383. https://doi.org/10.1001/jama.2020.17709.

34.Shang L., Wang L., Zhou F., Li J., Liu Y., Yang S. Long-term effects of obesity on COVID-19 patients

discharged from hospital // Immun Inflamm Dis. 2021. � 9(4). �.1678-1685. https://doi.org/10.1002/

iid3.522.

35. Siegelman J.N. Reflections of a COVID-19 long hauler // JAMA. 2020. Vol. 324. � 20. P. 2031-2032.

https://doi.org/10.1001/jama.2020.22130.

36.Stavem K., Ghanima W., Olsen M.K., Gilboe H.M., Einvik G. Persistent symptoms 1.5-6 months after

COVID-19 in non-hospitalised subjects: a population-based cohort study // Thorax. 2021. � 76(4). �.405�

407. https://doi.org/10.1136/thoraxjnl-2020-216377.

37.Subramanian A., Nirantharakumar K., Hughes S., Myles P., Williams T., Gokhale K.M., Taverner T.,

Chandan J.S., Brown K., Simms-Williams N., Shah A.D., Singh M., Kidy F., Okoth K., Hotham R., Bashir N.,

Cockburn N., Lee S.I., Turner G.M., Gkoutos G.V., Aiyegbusi O.L., McMullan C., Denniston A.K., Sapey E., Lord

J.M., Wraith D.C., Leggett E., Iles C., Marshall T., Price M.J., Marwaha S., Davies E.H., Jackson L.J., Matthews K.L.,

Camaradou J., Calvert M., Haroon S. Symptoms and risk factors for long COVID in non-hospitalized adults

// Nat Med. 2022. � 28(8). �.1706-1714. https://doi.org/10.1038/s41591-022-01909-w.

38.Talic S., Shah S., Wild H., Gasevic D., Maharaj A., Ademi Z., Li X., Xu W., Mesa-Eguiagaray I., Rostron

J., Theodoratou E., Zhang X., Motee A., Liew D., Ilic D. Effectiveness of public health measures in reducing

the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: systematic review and metaanalysis

// BMJ. 2021. Vol. 375. P. e068302. https://doi.org/10.1136/bmj-2021-068302.

39.Tang N., Li D., Wang X., Sun Z. Abnormal coagulation parameters are associated with poor prognosis

in patients with novel coronavirus pneumonia // J Thromb Haemost. 2020. Vol. 18. � 4. P. 844-847. https://

doi.org/10.1111/jth.14768.

40.World Health Organization. Coronavirus disease (COVID-19) outbreak (https://www.who.int).

41.Wulf Hanson S., Abbafati C., Aerts J.G., Al-Aly Z., Ashbaugh C., Ballouz T., Blyuss O., Bobkova P., Bonsel

G., Borzakova S., Buonsenso D., Butnaru D., Carter A., Chu H., De Rose C., Diab M.M., Ekbom E., El Tantawi M.,

Fomin V., Frithiof R., Gamirova A., Glybochko P.V., Haagsma J.A., Haghjooy Javanmard S., Hamilton E.B., Harris

G., Heijenbrok-Kal M.H., Helbok R., Hellemons M.E., Hillus D., Huijts S.M., Hultstrom M., Jassat W., Kurth F.,

Larsson I.M., Lipcsey M., Liu C., Loflin C.D., Malinovschi A., Mao W., Mazankova L., McCulloch D., Menges D.,

Mohammadifard N., Munblit D., Nekliudov N.A., Ogbuoji O., Osmanov I.M., Penalvo J.L., Petersen M.S., Puhan

M.A., Rahman M., Rass V., Reinig N., Ribbers G.M., Ricchiuto A., Rubertsson S., Samitova E., Sarrafzadegan

N., Shikhaleva A., Simpson K.E., Sinatti D., Soriano J.B., Spiridonova E., Steinbeis F., Svistunov A.A., Valentini

iНе можете найти то, что вам нужно? Попробуйте сервис подбора литературы.

P., van de Water B.J., van den Berg-Emons R., Wallin E., Witzenrath M., Wu Y., Xu H., Zoller T., Adolph C.,

Albright J., Amlag J.O., Aravkin A.Y., Bang-Jensen B.L., Bisignano C., Castellano R., Castro E., Chakrabarti S.,

Collins J.K., Dai X., Daoud F., Dapper C., Deen A., Duncan B.B., Erickson M., Ewald S.B., Ferrari A.J., Flaxman

A.D., Fullman N., Gamkrelidze A., Giles J.R., Guo G., Hay S.I., He J., Helak M., Hulland E.N., Kereselidze M.,

Krohn K.J., Lazzar-Atwood A., Lindstrom A., Lozano R., Malta D.C., Mansson J., Mantilla Herrera A.M., Mokdad

A.H., Monasta L., Nomura S., Pasovic M., Pigott D.M., Reiner R.C. Jr, Reinke G., Ribeiro A.L.P., Santomauro D.F.,

Sholokhov A., Spurlock E.E., Walcott R., Walker A., Wiysonge C.S., Zheng P., Bettger J.P., Murray C.J.L., Vos

T. Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom

clusters following symptomatic COVID-19 in 2020 and 2021 // JAMA. 2022. � 328(16). �.1604-15. https://

doi.org/10.1001/jama.2022.18931.

42.Xu E., Xie Y., Al-Aly Z. Long-term neurologic outcomes of COVID-19 // Nat Med. 2022. � 28(11).

�.2406-2415. https://doi.org/10.1038/s41591-022-02001-z.

43.Yang T., Yan M.Z., Li X., Lau E.H.Y. Sequelae of COVID-19 among previously hospitalized patients up

to 1 year after discharge: a systematic review and meta-analysis // Infection. 2022. � 50(5). �.1067�1109.

https://doi.org/10.1007/s15010-022-01862-3.

44.Yazji B., Voduc N., Mulpuru S., Cowan J. Pulmonary sequelae of SARS-CoV-2 infection and factors

associated with persistent abnormal lung function at six months after infection: Prospective cohort study //

PLoS One. 2022. � 17(11). �.e0277624. https://doi.org/10.1371/journal.pone.0277624.

References

1. Bakina AA, Pavlenko VI, Khripunova ��. Osobennosti rentgenologicheskoi kartiny COVID-19

� pnevmonii [Features of X-ray for pneumonia at Covid-19]. XXXII Natsional�nyi kongress po boleznyam

organov dykhaniya : sbornik trudov [XXXII National Congress on respiratory diseases. Collection of works of

Congress. Chucalin AG (ed.)]. Moscow: Design press; 2022. P. 77. (In Russ.)

2. Kulik EG, Pavlenko VI, Naryshkina SV. Pokazateli kachestva zhizni u bol�nykh KhOBL, perenesshikh

novuyu koronavirusnuyu infektsiyu [Indicators of the quality of life in patients with COPD and COVID-19].

XXXII Natsional�nyi kongress po boleznyam organov dykhaniya : sbornik trudov [XXXII National Congress on

respiratory diseases. Collection of works of Congress. Chucalin AG (ed.)]. Moscow: Design press; 2022. P. 130.

(In Russ.).

3. Kulik E.G., Pavlenko V.I., Naryshkina S.V. Sravnitel�nyi analiz kliniko-laboratornykh pokazatelei u

bol�nykh KhOBL v zavisimosti ot nalichiya obostreniya ili novoi koronavirusnoi infektsii [Comparative analysis

of clinical and laboratory features in patients with chronic obstructive pulmonary disease depending on the

presence of an exacerbation or a novel coronavirus infection]. Byulleten� fiziologii i patologii dykhaniya . �

Bulletin Physiology and Pathology of Respiration. 2022;85:26�31 (In Russ.). https://doi.org/10.36604/19985029-

2022-85-26-31.

4. Pavlenko V.I., Kulik E.G., Naryshkina S.V. Khronicheskaya obstruktivnaya bolezn� legkikh kak

komorbidnoe sostoyanie pri COVID-19 [Chronic obstructive pulmonary disease as a comorbid state in

Covid-19]. Amurskii meditsinskii zhurnal. � Amur Medical Journal. 2021;1(31):11�17. (In Russ.). https://doi.

org/10.24412/2311-5068-2021-1-11-17.

5. Ayoubkhani D, Khunti K, Nafilyan V, Maddox T, Humberstone B, Diamond I, Banerjee A. Post-COVID

syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ. 2021;372:n693.

https://doi.org/10.1136/bmj.n693.

6. Ceban F, Ling S, Lui LMW, Lee Y, Gill H, Teopiz KM, et al. Fatigue and cognitive impairment in Post-

COVID-19 Syndrome: A systematic review and meta-analysis. Brain Behav Immun. 2022;101:93-135. https://

doi.org/10.1016/j.bbi.2021.12.020.

7. Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, et al. A familial cluster of pneumonia associated with

the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet.

2020;395:514-523. https://doi.org/10.1016/S0140-6736(20)30154-9.

8. Changeux JP, Amoura Z, Rey FA, Miyara M. A nicotinic hypothesis for COVID-19 with preventive and

therapeutic implications. C R Biol. 2020;343(1):1�7. https://doi.org/10.5802/crbiol.8. PMID: 32720486.

9. Chudzik M, Babicki M, Kapusta J, Kaluzinska-Kolat Z, Kolat D, Jankowski P., Mastalerz-Migas A.

Long-COVID clinical features and risk factors: a retrospective analysis of patients from the STOP-COVID

registry of the PoLoCOV study. Viruses. 2022;14(8):1755. https://doi.org/10.3390/v14081755.

10.Chung TH, Azar A. Autonomic nerve involvement in post-acute sequelae of SARS-CoV-2 syndrome

(PASC). J Clin Med. 2022;12(1):73. https://doi.org/10.3390/jcm12010073.

11. Coronavirus disease (COVID-19) � World Health Organization. Available from: https://www.who.int/

emergencies/diseases/novel-coronavirus-2019. [Accessed: June 27, 2021]

12. Davis HE, Assaf G.S, McCorkell L, Wei H, Low RJ, Re�em Y., et al. Characterizing long COVID in an

international cohort: 7 months of symptoms and their impact. E Clinical Medicine. 2021;38:101019. https://

doi.org/10.1016/j.eclinm.2021.101019.

13. Feikin DR, Higdon MM, Abu-Raddad LJ, Andrews N, Araos R, Goldberg Y., et al. Duration of

effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review

and meta-regression. Lancet. 2022;399:924-44. https://doi.org/10.1016/S0140-6736(22)00152-0.

14. Fernandez-de-Las-Penas C, Gomez-Mayordomo V, Cuadrado ML, Palacios-Cena D, Florencio LL,

Guerrero AL., et al. The presence of headache at onset in SARS-CoV-2 infection is associated with longterm

post-COVID headache and fatigue: A case-control study. Cephalalgia. 2021:41(13):1332-41. https://doi.

org/10.1177/03331024211020404.

15. Fernandez-de-Las-Penas C, Guijarro C, Torres-Macho J, Velasco-Arribas M, Plaza-Canteli S,

Hernandez-Barrera V., et al. Diabetes and the risk of long-term post-COVID symptoms. Diabetes. 2021;

70(12):2917-21. https://doi.org/10.2337/db21-0329.

16. Fernandez-de-Las-Penas C., Rodriguez-Jimenez J., Cancela-Cilleruelo I., Guerrero-Peral A., Martin-

Guerrero J.D., Garcia-Azorin D., et al. Post-COVID-19 symptoms 2 years after SARS-CoV-2 infection among

hospitalized vs nonhospitalized patients. JAMA Netw Open. 2022;5(11):e2242106. https://doi.org/10.1001/

jamanetworkopen.2022.42106.

17. Fernandez-de-Las-Penas C, Ryan-Murua P, Rodriguez-Jimenez J, Palacios-Cena M, Arendt-Nielsen L,

Torres-Macho J. Serological biomarkers at hospital admission are not related to long-term post-COVID fatigue

and dyspnea in COVID-19 survivors. Respiration. 2022;101(7):658-665. https://doi.org/10.1159/000524042.

18. Goertz YMJ, Van Herck M, Delbressine JM, Vaes AW, Meys R, Machado FVC, Houben-Wilke S, Burtin

C, Posthuma R, Franssen FME, van Loon N, Hajian B, Spies Y, Vijlbrief H, van �t Hul AJ, Janssen DJA, Spruit

MA. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open

Res. 2020 Oct 26;6(4):00542-2020. https://doi.org/10.1183/23120541.00542-2020. PMID: 33257910; PMCID:

PMC7491255.

19. Guntur VP, Nemkov T, de Boer E, Mohning MP, Baraghoshi D, Cendali FI., et al. Signatures of

mitochondrial dysfunction and impaired fatty acid metabolism in plasma of patients with post-acute

sequelae of COVID-19 (PASC). Metabolites. 2022;12(11):1026. https://doi.org/10.3390/metabo12111026.

20. Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H., et al. Washington State 2019

nCoV Case Investigation Team. First Case of 2019 Novel Coronavirus in the United States. N Engl J Med.

2020;382;10:929-936. https://doi.org/10.1056/NEJMoa2001191.

21. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y., et al. Clinical features of patients infected with 2019 novel

coronavirus in Wuhan, China. Lancet. 2020;395:497-506. https://doi.org/10.1016/S0140-6736(20)30183-5.

22. Kamal M, Abo Omirah M, Hussein A, Saeed H. Assessment and characterisation of post-COVID-19

manifestations. Int J Clin Pract. 2021;75:e13746. https://doi.org/10.1111/ijcp.13746.

23. Lee JH, Yim JJ, Park J. Pulmonary function and chest computed tomography abnormalities 6-12

months after recovery from COVID-19: a systematic review and meta-analysis. Respir Res. 2022;23(1):233.

Https://doi.org/10.1186/s12931-022-02163-x.

24. Liang L, Yang B, Jiang N, Fu W, He X, Zhou Y., et al. Three-month Follow-up Study of Survivors of

Coronavirus Disease 2019 after Discharge. J Korean Med Sci. 2020;35(47):e418. https://doi.org/10.3346/

jkms.2020.35.e418.

25. Loosen SH, Jensen BO, Tanislav C, Luedde T, Roderburg C, Kostev K. Obesity and lipid metabolism

disorders determine the risk for development of long COVID syndrome: a cross-sectional study from 50,402

COVID-19 patients. Infection. 2022;50(5):1165-1170. https://doi.org/10.1007/s15010-022-01784-0.

iНе можете найти то, что вам нужно? Попробуйте сервис подбора литературы.

26. Mizrahi B, Sudry T, Flaks-Manov N, Yehezkelli Y, Kalkstein N, Akiva P., et al. Long COVID outcomes

at one year after mild SARS-CoV-2 infection: nationwide cohort study. BMJ. 2023;380:e072529. https://doi.

org/10.1136/bmj-2022-072529.

27. Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS., et al. Post-acute COVID-19

syndrome. Nat Med. 2021;27;4:601-615. https://doi.org/10.1038/s41591-021-01283-z.

28. Nateghi S, Hesari E, Mansouri F, Akrami M, Pourian M, Khosravani A., et al. Evaluation of blood

biochemistry and cardiopulmonary status of hospitalized COVID-19 patients in 3 months post discharged

follow up survey. Clin Med Insights Circ Respir Pulm Med. 2022;16:11795484221119332. https://doi.

org/10.1177/11795484221119332.

29. Notarte KI, de Oliveira MHS., Peligro PJ, Velasco JV, Macaranas I, Ver AT., et al. Age, sex and previous

comorbidities as risk factors not associated with SARS-CoV-2 infection for long COVID-19: A Systematic

Review and Meta-Analysis. J Clin Med. 2022;11(24):7314. https://doi.org/10.3390/jcm11247314.

30. Peghin M, Palese A, Venturini M, De Martino M, Gerussi V, Graziano E., et al. Post-COVID-19

symptoms 6 months after acute infection among hospitalized and non-hospitalized patients. Clin Microbiol

Infect. 2021;27(10):1507-1513. https://doi.org/10.1016/j.cmi.2021.05.033.

31. Phan LT, Nguyen TV, Luong QC, Nguyen TV, Nguyen HT, Le HQ., et al. Importation and Humanto-

Human Transmission of a Novel Coronavirus in Vietnam. N Engl J Med. 2020;382;9:872-874. https://doi.

org/10.1056/NEJMc2001272.

32.Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C., et al. Transmission of 2019nCoV

Infection from an Asymptomatic Contact in Germany. N Engl J Med. 2020;382;10:970�971. https://doi.

org/10.1056/NEJMc2001468.

33. Rubin R. As their numbers grow, COVID-19 �Long haulers� stump experts. JAMA. 2020;324;14:13811383.

https://doi.org/10.1001/jama.2020.17709.

34.Shang L, Wang L, Zhou F, Li J, Liu Y, Yang S. Long-term effects of obesity on COVID-19 patients

discharged from hospital. Immun Inflamm Dis. 2021;9(4);1678-1685. https://doi.org/10.1002/iid3.522.

35. Siegelman JN. Reflections of a COVID-19 long hauler. JAMA. 2020;324;20:2031-2032. https://doi.

org/10.1001/jama.2020.22130.

36. Stavem K, Ghanima W, Olsen MK, Gilboe HM, Einvik G. Persistent symptoms 1.5-6 months after

COVID-19 in non-hospitalised subjects: a population-based cohort study. Thorax. 2021;76(4):405-407.

https://doi.org/ 10.1136/thoraxjnl-2020-216377.

37. Subramanian A, Nirantharakumar K, Hughes S, Myles P, Williams T, Gokhale KM., et al. Symptoms

and risk factors for long COVID in non-hospitalized adults. Nat Med. 2022;28(8):1706-14. https://doi.

org/10.1038/s41591-022-01909-w.

38. Talic S, Shah S, Wild H, Gasevic D, Maharaj A, Ademi Z., et al. Effectiveness of public health measures

in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: systematic review

and meta-analysis. BMJ. 2021;375:e068302. https://doi.org/10.1136/bmj-2021-068302.

39. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in

patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18;4:844-847. https://doi.org/10.1111/

jth.14768.

40. World Health Organization. Coronavirus disease (COVID-19) outbreak. Available from:

https://www.who.int.

41. Wulf Hanson S, Abbafati C, Aerts JG, Al-Aly Z, Ashbaugh C, Ballouz T., et al. Estimated global

proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following

symptomatic COVID-19 in 2020 and 2021. JAMA. 2022;328(16):1604-1615. https://doi.org/10.1001/

jama.2022.18931.

42. Xu E, Xie Y, Al-Aly Z. Long-term neurologic outcomes of COVID-19. Nat Med. 2022;28(11):24062415.

Https://doi.org/10.1038/s41591-022-02001-z.

43. Yang T, Yan MZ, LiX, Lau EHY. Sequelae of COVID-19 among previously hospitalized patients up to

1 year after discharge: a systematic review and meta-analysis. Infection. 2022;50(5):1067-1109. https://doi.

org/10.1007/s15010-022-01862-3.

44. Yazji B, Voduc N, Mulpuru S, Cowan J. Pulmonary sequelae of SARS-CoV-2 infection and factors

associated with persistent abnormal lung function at six months after infection: Prospective cohort study.

PLoS One. 2022;17(11):e0277624. https://doi.org/10.1371/journal.pone.0277624.

�� :

��

�� ; �� : 8924-446-50-08; �-mail: anastasia_darchi@

mail.ru

�� -�. ��. ��, ��, ��

�� ; �� : 8962-284-6290;

�-mail: agmapedfac@mail.ru

��

�� ; �� : 8914-599-54-35; �-mail: shchegortsova92@

mail.ru

�� 20.03.2023; �� 12.06.2023; �� 08.08.2023.

The article was submitted 20.03.2023; approved after reviewing 12.06.2023; accepted for publication 08.08.2023.

Постковидный синдром – что мы знаем о нем? Текст научной статьи по специальности «Клиническая медицина»

Аннотация научной статьи по клинической медицине, автор научной работы — Бакина Анастасия Алексеевна, Павленко Валентина Ивановна, Щегорцова Юлия Юрьевна

Похожие темы научных работ по клинической медицине , автор научной работы — Бакина Анастасия Алексеевна, Павленко Валентина Ивановна, Щегорцова Юлия Юрьевна

What do we know about post-COVID syndrome?

Текст научной работы на тему «Постковидный синдром – что мы знаем о нем?»